RhoVac marketed in international press
RhoVac AB (”RhoVac”) is marketed in the latest edition of the international trade press outlet, MedNous, through a written commentary by CEO Anders Månsson.In order to further attract the attention of potential partners and increase their interest in RhoVac’s achievements as well as plans for the future, RhoVac’s CEO Anders Månsson has written a commentary on the company in the latest edition of MedNous that was published last week. CEO Anders Månsson comments: “It is important that we market RhoVac more broadly than what can be accomplished in direct bi-lateral meetings, whether